DK1137407T3 - Fremgangsmåde til fremstilling af en formulering af topisk beta-blokkere med forbedret effektivitet - Google Patents

Fremgangsmåde til fremstilling af en formulering af topisk beta-blokkere med forbedret effektivitet

Info

Publication number
DK1137407T3
DK1137407T3 DK99905124T DK99905124T DK1137407T3 DK 1137407 T3 DK1137407 T3 DK 1137407T3 DK 99905124 T DK99905124 T DK 99905124T DK 99905124 T DK99905124 T DK 99905124T DK 1137407 T3 DK1137407 T3 DK 1137407T3
Authority
DK
Denmark
Prior art keywords
formulation
preparing
improved efficacy
beta blockers
topical beta
Prior art date
Application number
DK99905124T
Other languages
Danish (da)
English (en)
Inventor
Bakulesh Mafatlal Khamar
Original Assignee
Bakulesh Mafatlal Khamar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bakulesh Mafatlal Khamar filed Critical Bakulesh Mafatlal Khamar
Application granted granted Critical
Publication of DK1137407T3 publication Critical patent/DK1137407T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99905124T 1998-12-11 1999-03-04 Fremgangsmåde til fremstilling af en formulering af topisk beta-blokkere med forbedret effektivitet DK1137407T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LK1157898 1998-12-11
PCT/IB1999/000378 WO2000035439A1 (en) 1998-12-11 1999-03-04 The process for manufacturing formulation of topical beta blockers with improved efficacy

Publications (1)

Publication Number Publication Date
DK1137407T3 true DK1137407T3 (da) 2004-05-10

Family

ID=19720977

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99905124T DK1137407T3 (da) 1998-12-11 1999-03-04 Fremgangsmåde til fremstilling af en formulering af topisk beta-blokkere med forbedret effektivitet

Country Status (10)

Country Link
EP (1) EP1137407B1 (de)
AP (1) AP2001002206A0 (de)
AU (1) AU770365B2 (de)
BR (1) BR9916107A (de)
CA (1) CA2354765A1 (de)
DK (1) DK1137407T3 (de)
EA (1) EA004050B1 (de)
IL (1) IL143687A0 (de)
RU (1) RU2218156C2 (de)
WO (1) WO2000035439A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008055205A2 (en) * 2006-10-31 2008-05-08 Alcon Research, Ltd. Pai-1 binding modulators for the treatment of ocular disorders
CN104189906A (zh) 2007-01-29 2014-12-10 V生命科学技术有限公司 用于治疗糖尿病并发症的药用组合物
EP4126076A1 (de) 2020-03-31 2023-02-08 Sentiss Pharma Private Limited Sterilisationsverfahren von timololgelbildender lösung durch aseptische filtration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
IE62871B1 (en) * 1988-03-08 1995-03-08 Warner Lambert Co Compositions with enhanced penetration
JPH0773394B2 (ja) * 1988-03-09 1995-08-02 富士通株式会社 異種通信網の一元的通信網への統合方法
EP0582321A1 (de) * 1992-01-17 1994-02-09 Gramer, Eugen, Prof.Dr.med.Dr.jur. Kombinationspräparat auf der Basis von Dipivalylepinephrin (DPE) und Betablocker zur Augeninnendrucksenkung

Also Published As

Publication number Publication date
CA2354765A1 (en) 2000-06-22
EA200100655A1 (ru) 2002-04-25
EA004050B1 (ru) 2003-12-25
AP2001002206A0 (en) 2001-09-30
EP1137407B1 (de) 2004-02-18
BR9916107A (pt) 2002-04-30
EP1137407A1 (de) 2001-10-04
AU770365B2 (en) 2004-02-19
IL143687A0 (en) 2002-04-21
WO2000035439A1 (en) 2000-06-22
AU2541199A (en) 2000-07-03
RU2218156C2 (ru) 2003-12-10

Similar Documents

Publication Publication Date Title
DK1296656T3 (da) Fremgangsmåde til fremstilling af et præparat
PT1077957E (pt) Derivados do acido oxi-iminoalcanoico
DK0708114T3 (da) Fremgangsmåde til fremstilling af alkylerede galactomannaner
DK2332915T3 (da) beta2-Adrenoceptoragonister
DK1317181T3 (da) Fremgangsmåde til fremstilling af en herbicid faststofformulering
PT1105382E (pt) Metodo para a preparacao de citalopran
NO20003131D0 (no) Krystallinsk teriparatid
DK1150966T3 (da) Fremgangsmåde til fremstilling af 5-cyanophthalid
DK1140034T3 (da) Formulering af divalproex-natrium med kontrolleret frigivelse
NO20022624L (no) Heterocyklo-alkylsulfonylderivater som anti- inflammatoriske/smertestillende midler
DK1065938T3 (da) Fremgangsmåde til fremstilling af et smøremateriale
NO20020030D0 (no) Krystallinske 1-metylcarbapenemforbindelser
PT1147075E (pt) Processo para a preparacao de cloridrato de l-fenilefrina
BR9711201A (pt) Processo para a prepara-ao de um composto
DK1272489T3 (da) Fremgangsmåde til præparation af cabergolins krystallinske form I
DK1005444T3 (da) Fremgangsmåde til fremstilling af aromatiske aminer
ID28121A (id) Proses pembuatan sediaan-sediaan optalmik topikal tanpa efek-efek sistematik
ATE277016T1 (de) Beta-alaninderivate
NO995851D0 (no) Fremstillingsfremgangsmåte for isoksasolidinedion forbindelse
DK1137407T3 (da) Fremgangsmåde til fremstilling af en formulering af topisk beta-blokkere med forbedret effektivitet
NO20004016L (no) Kosmetisk preparat inneholdende en forbindelse med aktivitetsstimulerende interlevkin-6
DK0970073T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK1308454T3 (da) Fremgangsmåde til fremstilling af platinforbindelse
IS5821A (is) Kristalluð form af ósanetant
PT1240173E (pt) Processo para a preparacao de n-fosfonometilglicina